E
84.15
4.43 (5.56%)
| Previous Close | 79.72 |
| Open | 82.50 |
| Volume | 11,798,864 |
| Avg. Volume (3M) | 4,999,141 |
| Market Cap | 48,515,985,408 |
| Price / Earnings (TTM) | 46.49 |
| Price / Earnings (Forward) | 27.70 |
| Price / Sales | 7.68 |
| Price / Book | 4.62 |
| 52 Weeks Range | |
| Earnings Date | 23 Jul 2026 |
| Profit Margin | 75.71% |
| Operating Margin (TTM) | 29.01% |
| Diluted EPS (TTM) | 2.42 |
| Quarterly Revenue Growth (YOY) | 6.20% |
| Quarterly Earnings Growth (YOY) | 1.70% |
| Total Debt/Equity (MRQ) | 6.86% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 876.20 M |
| Levered Free Cash Flow (TTM) | 1.45 B |
| Return on Assets (TTM) | 8.42% |
| Return on Equity (TTM) | 16.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Edwards Lifesciences Corporatio | Bullish | Bullish |
AIStockmoo Score
0.3
| Analyst Consensus | 5.0 |
| Insider Activity | -3.0 |
| Price Volatility | -3.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Average | 0.30 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.91% |
| % Held by Institutions | 89.29% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 103.00 (BTIG, 22.40%) | Buy |
| Median | 100.00 (18.84%) | |
| Low | 89.00 (Truist Securities, 5.76%) | Hold |
| Average | 97.40 (15.75%) | |
| Total | 4 Buy, 1 Hold | |
| Avg. Price @ Call | 79.33 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 11 Feb 2026 | 103.00 (22.40%) | Buy | 79.33 |
| Goldman Sachs | 11 Feb 2026 | 95.00 (12.89%) | Buy | 79.33 |
| Piper Sandler | 11 Feb 2026 | 100.00 (18.84%) | Buy | 79.33 |
| Truist Securities | 11 Feb 2026 | 89.00 (5.76%) | Hold | 79.33 |
| Wells Fargo | 11 Feb 2026 | 100.00 (18.84%) | Buy | 79.33 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BOBO DONALD E JR | - | 83.98 | -469 | -39,387 |
| CHOPRA DAVEEN | - | 83.98 | -282 | -23,682 |
| LIPPIS DANIEL J. | - | 83.76 | -2,290 | -191,652 |
| ULLEM SCOTT B. | - | 83.45 | -11,751 | -974,939 |
| ZOVIGHIAN BERNARD J | 82.91 | 83.45 | -515 | -43,250 |
| Aggregate Net Quantity | -15,307 | |||
| Aggregate Net Value ($) | -1,272,909 | |||
| Aggregate Avg. Buy ($) | 82.91 | |||
| Aggregate Avg. Sell ($) | 83.67 | |||
| Insider Range ($) | ||||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ZOVIGHIAN BERNARD J | Officer | 05 May 2026 | Disposed (-) | 523 | 82.91 | 43,362 |
| ZOVIGHIAN BERNARD J | Officer | 05 May 2026 | Acquired (+) | 523 | 82.91 | 43,362 |
| ULLEM SCOTT B. | Officer | 05 May 2026 | Disposed (-) | 11,131 | 82.91 | 922,871 |
| ULLEM SCOTT B. | Officer | 05 May 2026 | Option execute | 13,000 | - | - |
| LIPPIS DANIEL J. | Officer | 04 May 2026 | Sell (-) | 1,019 | 83.33 | 84,913 |
| LIPPIS DANIEL J. | Officer | 04 May 2026 | Option execute | 1,019 | - | - |
| BOBO DONALD E JR | Officer | 03 May 2026 | Disposed (-) | 469 | 83.98 | 39,387 |
| CHOPRA DAVEEN | Officer | 03 May 2026 | Disposed (-) | 282 | 83.98 | 23,682 |
| LIPPIS DANIEL J. | Officer | 03 May 2026 | Disposed (-) | 252 | 83.98 | 21,163 |
| ZOVIGHIAN BERNARD J | Officer | 03 May 2026 | Disposed (-) | 515 | 83.98 | 43,250 |
| ULLEM SCOTT B. | Officer | 03 May 2026 | Disposed (-) | 620 | 83.98 | 52,068 |
| LIPPIS DANIEL J. | Officer | 01 May 2026 | Automatic sell (-) | 1,019 | 83.98 | 85,576 |
| LIPPIS DANIEL J. | Officer | 01 May 2026 | Option execute | 1,019 | - | - |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |